Adicet Bio, Inc. SEC filings ACET
Adicet Bio, Inc. has 682 filings in SEC EDGAR's recent list, going back to Oct 27, 2017. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 26.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Apr 29, 2026 |
| DEF 14A | Proxy statement | Nov 17, 2025 | Dec 19, 2025 |
| PRE 14A | Preliminary proxy statement | Nov 5, 2025 | Dec 19, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Apr 29, 2025 |
| DEFA14A | Additional proxy material | Apr 23, 2024 | — |
| DEF 14A | Proxy statement | Apr 23, 2024 | Apr 23, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 12, 2024 | Apr 12, 2024 |
| DEF 14A | Proxy statement | Apr 18, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 18, 2023 | — |
| DEFA14A | Additional proxy material | Apr 21, 2022 | — |
| DEF 14A | Proxy statement | Apr 21, 2022 | Jun 2, 2022 |
| DEFA14A | Additional proxy material | Mar 18, 2021 | — |
| DEF 14A | Proxy statement | Mar 18, 2021 | Apr 27, 2021 |
| DEFA14A | Additional proxy material | Apr 30, 2020 | — |
| DEFA14A | Additional proxy material | Mar 27, 2020 | — |
| DEF 14A | Proxy statement | Mar 27, 2020 | May 6, 2020 |
| DEFA14A | Additional proxy material | Mar 27, 2019 | — |
| DEF 14A | Proxy statement | Mar 27, 2019 | May 8, 2019 |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ACET (Nasdaq)
- Fiscal year ends
- December 26
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1720580
- Former names
- resTORbio, Inc. (until Aug 21, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.